Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health.
News
CellMax Life Shares Positive Results From Validation Study for FirstSight Blood Test for Detection of Colorectal Cancer and Pre-cancerous Advanced Adenomas
Jan. 26, 2024 - CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, presented the latest results from its independent external validation study on January 20, 2024 at the ASCO Gastroin
Read more
Report
FDA Proposal Casts Cloud Over Startups in Lab-Testing Market
Oct 05, 2023 - A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups are advancing an array of tests to detect diseases sooner and personalize treatments. The post FDA Proposal Casts Cloud Over Startups i
Read more
Report
CellMax Life Appoints Dr. Ross D. "Rusty" Segan to Advisory Board
CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer (CRC) screening blood test, that also detects pre-cancerous polyps, or adenomas, today announced the appointment of Dr. Ross D. Segan as an advisory board member. The post
Read more
Report
People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx
Apr 06, 2023 - Molecular diagnostics company CellMax Life has appointed Stan Lapidus and Ron Andrews to its The post People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx appeared first on CellMax Life.
Read more
Report
CellMax Life Announces Expansion of Company Board With Leading Industry Experts
Feb 21, 2023 - Renowned industry experts support the company as it prepares for premarket approval studies The post CellMax Life Announces Expansion of Company Board With Leading Industry Experts appeared first on CellMax Life.
Read more
Report
CellMax Life Announces Expansion of GI Medical Advisory Board
Feb 21, 2023 - Renowned industry experts support the company as it prepares for premarket approval studies The post CellMax Life Announces Expansion of GI Medical Advisory Board appeared first on CellMax Life.
Read more
Report
Dr. Friedland on a Multimodal Screening Blood Test to Detect CRC
Feb 10, 2023 - Shai Friedland, MD, discusses a multimodal screening blood test for advanced adenomas in colorectal cancer. The post Dr. Friedland on a Multimodal Screening Blood Test to Detect CRC appeared first on CellMax Life.
Read more
Report
CellMax Life announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly accurate in detecting colorectal cancer and advanced adenomas.
Jan 26, 2023 - CellMax Life announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly accurate in detecting colorectal cancer and advanced adenomas. The post CellMax Life announced positive results from a
Read more
Report
Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid
NEW YORK; Jan 19, 2023 - Cancer screening firm CellMax Life shared new data this week from a multi-site prospective study of its blood-based colorectal cancer detection assay, FirstSight. The post Colorectal Cancer Detection Data from CellMax Life Bodes W
Read more
Report
CellMax Life Announces Positive Results From Prospective Multisite Study of Novel Blood Test to Detect Colorectal Cancer and Pre-Cancer
SUNNYVALE, CA; January 18, 2023 - CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly ac
Read more
Report
Show more news
